Barrons.com47d agobullish
Viking Therapeutics Stock Surges 30%. It Could Challenge Lilly and Novo’s Obesity Empire.News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
107last 24h
3125last 7d
511● bullish (7d)
311● bearish (7d)
227publishers
Investor's Business Daily47d agobearish
Viking Therapeutics Skyrockets On Obesity Drug Data. Eli Lilly, Novo Fall.InvestorsHub47d agoneutral
Novo Nordisk Considers Acquisitions to Expand Weight-Loss Drug Pipeline as Competition IntensifiesBloomberg48d agobearishVIDEO
Accenture Up on Partnership with Anthropic; Novo Nordisk Falls on Turnaround | Stock MoversBarrons.com48d agoneutral
Why Novo Stock Is Dropping After Drugmaker Unveils Ambitious Growth PlanThe Wall Street Journal48d agoneutral
Wegovy Maker Novo Looks to New Drugs to Combat Lilly, but Investors Are UnconvincedYahoo Finance48d agoneutral
Novo Nordisk stock gets drilled on pipeline concerns - its CEO sees a main problemYahoo Finance48d agoneutral
Novo Nordisk stock gets drilled on pipeline concerns - its CEO sees this as the main problemYahoo Finance48d agoneutral
Novo Nordisk stock gets drilled on pipeline concerns -- its CEO sees this as the main problemThe Wall Street Journal48d agoneutral
Wegovy Maker Novo Nordisk Targets Several New Blockbuster Drugs in Coming YearsReuters53d agoneutral
Advil-maker Haleon boosts US sales by targeting consumers on weight-loss drugs